Terms: = Lung cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
1538 results:
1. PRMT5-mediated methylation of stat3 is required for lung cancer stem cell maintenance and tumour growth.
Abe Y; Sano T; Otsuka N; Ogawa M; Tanaka N
Commun Biol; 2024 May; 7(1):593. PubMed ID: 38760429
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/stat3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract] [Full Text] [Related]
3. Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on lung cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.
Das R; Woo J
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731403
[TBL] [Abstract] [Full Text] [Related]
4. Blueberry extract and its bioactive compounds mitigate oxidative stress and suppress human lung cancer cell (A549) growth by modulating the expression of p53/EGFR/stat3/IL6-mediated signaling molecules.
Krishnamoorthy K; Natarajan SR; Veeraraghavan VP; Jayaraman S
Cell Biochem Funct; 2024 Jun; 42(4):e4027. PubMed ID: 38715184
[TBL] [Abstract] [Full Text] [Related]
5. Metochalcone induces senescence-associated secretory phenotype via JAK2/stat3 pathway in breast cancer.
Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
[TBL] [Abstract] [Full Text] [Related]
6. Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced stat3-activation in non-small cell lung cancer.
Li Y; Sun H; Bai C; Hu Y; Tang J; Zhang Y; Chen J; Zhong Z; He Y; Hu K; Yang J
Int Immunopharmacol; 2024 May; 133():112157. PubMed ID: 38678671
[TBL] [Abstract] [Full Text] [Related]
7. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/stat3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract] [Full Text] [Related]
8. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
[TBL] [Abstract] [Full Text] [Related]
9. The endonuclease FEN1 mediates activation of stat3 and facilitates proliferation and metastasis in breast cancer.
Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
[TBL] [Abstract] [Full Text] [Related]
10. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating stat3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
11. Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models.
Salembier R; De Haes C; Bellemans J; Demeyere K; Van Den Broeck W; Sanders NN; Van Laere S; Lyons TR; Meyer E; Steenbrugge J
Breast Cancer Res; 2024 Apr; 26(1):63. PubMed ID: 38605414
[TBL] [Abstract] [Full Text] [Related]
12. [High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the JAK1/stat3/KHSRP axis].
Zhang F; Fan L; Kang X; Wei H; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):541-552. PubMed ID: 38597446
[TBL] [Abstract] [Full Text] [Related]
13. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent stat3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract] [Full Text] [Related]
14. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Saeed AF; Kluz T; Costa M; Shroyer KR; Kondo K; Wang Z; Yang C
Cancer Lett; 2024 May; 589():216827. PubMed ID: 38527692
[TBL] [Abstract] [Full Text] [Related]
15. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
16. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell lung cancer Cells by Inhibiting MCL-1 Expression via MET/stat3/Akt Pathway.
Wang L; Xu L; Han S; Zhu X
Can Respir J; 2024; 2024():2632014. PubMed ID: 38468814
[TBL] [Abstract] [Full Text] [Related]
17. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract] [Full Text] [Related]
18. IL6-stat3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
[TBL] [Abstract] [Full Text] [Related]
19. 5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells.
Chen HC; Kuo CY; Chang Y; Tsai DL; Lee MH; Lee JY; Lee HM; Su YC
BMC Cancer; 2024 Feb; 24(1):248. PubMed ID: 38388902
[TBL] [Abstract] [Full Text] [Related]
20. A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of stat3 and negative regulation of JAK2-stat3 pathway.
Cao F; Li M; Wang W; Yi Y; Chen Y; Liu H
Biochem Pharmacol; 2024 Apr; 222():116068. PubMed ID: 38387529
[TBL] [Abstract] [Full Text] [Related]
[Next]
